Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility

This study aimed to compare the determinants and impact of hepatocellular carcinoma (HCC) surveillance rates for people with metabolic dysfunction-associated steatotic liver disease (MASLD) versus other chronic liver diseases. A dataset of HCC patients from a UK hospital (2007-2022) was analyzed. Th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastroenterology and hepatology 2024-12, Vol.39 (12), p.2817-2825
Hauptverfasser:	Henry-Blake, Connor, Balachandrakumar, Vinay, Kassab, Mohamed, Devonport, Joshua, Matthews, Charmaine, Fox, James, Baggus, Elisabeth, Henney, Alexander, Stern, Nicholas, Cuthbertson, Daniel J, Palmer, Daniel, Johnson, Philip J, Hughes, David M, Hydes, Theresa J, Cross, Timothy J S
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Carcinoma, Hepatocellular - etiology Cirrhosis Fatty Liver - complications Female Hepatocellular carcinoma Humans Liver cancer Liver cirrhosis Liver diseases Liver Neoplasms - epidemiology Liver Neoplasms - etiology Liver Neoplasms - pathology Male Metabolic Diseases - complications Metabolic Diseases - epidemiology Metabolism Middle Aged Original ‐ Hepatology (Clinical) Patients Proportional Hazards Models Surveillance Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!